1. 1Note for Guidance on the Investigation of Bioavailability and Bioequivalence (NfG on BA/BE), CPMP/EWP/QWP/1401/98.
2. 2Drug Bioequivalence. A Report of the Office of Technology Assessment. Drug Bioequivalence Study Panel, July 1974, NTIS (USA).
3. 3European Guideline. Investigation of Bioavailability and Bioequivalence, The Rules Governing Medicinal Products in the European Union, June 1992.
4. 4Questions & Answers on the Note for Guidance on the Investigation of Bioavailability and Bioequivalence, EMEA/CHMP/EWP/40326/2006.
5. 5Directive 2001/83/EC as amended by Parliament and Council Directive 2004/27.